Problems and pitfalls of the hepatocyte-specific contrast agent gadoxetate disodium for assessing the main criteria of LI-RADS version 2018
10.3760/cma.j.cn501113-20230725-00018
- VernacularTitle:肝细胞特异性对比剂钆塞酸二钠评估2018版肝脏影像报告和数据系统主要征象的问题和陷阱
- Author:
Ran GUO
1
;
Shaocheng ZHU
Author Information
1. 河南省人民医院 郑州大学人民医院放射科 450003
- Keywords:
Hepatocellular carcinoma;
Magnetic resonance imaging;
Hepatocyte-specific contrast medium
- From:
Chinese Journal of Hepatology
2023;31(8):886-890
- CountryChina
- Language:Chinese
-
Abstract:
Although main criteria like non-rim enhancement in the arterial phase, non-peripheral washout, enhancing envelope, lesion size, and threshold growth have definitions and interpretations in the Liver Imaging Reporting and Data System, there are still some problems and pitfalls that clinicians and radiologists need to understand and avoid when assessing the main criteria based on gadoxetate disodium in clinical work-up. This article reviews the existing problems and current solutions in the assessment of the main criteria based on the hepatic contrast agent gadoxetate disodium.
